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710High Dietary Intake of Vegetable Protein Is
Associated With Lower Prevalence of Renal
Function Impairment: Results of the Dutch
DIALECT-1 Cohort
Milou M. Oosterwijk1,2, Sabita S. Soedamah-Muthu3,4, Johanna M. Geleijnse2,
Stephan J.L. Bakker5, Gerjan Navis5, S. Heleen Binnenmars5, Christina M. Gant1,5 and
Gozewijn D. Laverman1,5
1Department of Internal Medicine/Nephrology, Ziekenhuis Groep Twente, Almelo, the Netherlands; 2Division of Human
Nutrition, Wageningen University, Wageningen, the Netherlands; 3Center of Research on Psychological and Somatic Disorders
(CoRPS), Department of Medical and Clinical Psychology, Tilburg University, Tilburg, the Netherlands; 4Institute for Food,
Nutrition and Health, University of Reading, Reading, UK; and 5Department of Internal Medicine, Division of Nephrology,
University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsIntroduction: Dietary protein intake may inﬂuence development of renal function impairment in diabetes
mellitus type 2 (T2DM). We assessed the association between sources of protein and prevalence of renal
function impairment.
Methods: Cross-sectional analyses were performed in baseline data of 420 patients of the DIAbetes and
LifEstyle Cohort Twente-1 (DIALECT-1) study. Protein intake was assessed using a Food Frequency
Questionnaire, modiﬁed for accurate assessment of protein intake, including types and sources of protein.
Renal function impairment was deﬁned as estimated glomerular ﬁltration rate (eGFR) <60 ml/min per 1.73
m2 (Chronic Kidney Disease Epidemiology Collaboration formula).
Results: Among 420 patients with T2DM, 99 renal function impairment cases were identiﬁed. Multivariate
Cox proportional hazard models were used and adjusted for the main lifestyle and dietary factors. The
prevalence ratios in the fully adjusted model were 1 (reference), 0.74 (95% conﬁdence interval [CI]: 0.44–
1.27; P ¼ 0.28) and 0.47 (95% CI: 0.23–0.98; P ¼ 0.04) according to increasing tertiles of vegetable protein
intake. For animal protein intake the prevalence ratios were 1 (reference), 1.10 (95% CI: 0.64–1.88; P ¼ 0.74)
and 1.06 (95% CI: 0.56–1.99; P ¼ 0.87) according to increasing tertiles of intake. Theoretical replacement
models showed that replacing 3 energy percent from animal protein by vegetable protein lowered the
prevalence ratio for the association with renal function impairment to 0.20 (95% CI: 0.06–0.63; P ¼ 0.01).
Conclusion: In conclusion, we found that higher intake of vegetable protein was associated with a lower
prevalence of renal function impairment, and theoretical replacement of animal protein with vegetable
protein was inversely associated with renal function impairment among patients with T2DM.
Kidney Int Rep (2019) 4, 710–719; https://doi.org/10.1016/j.ekir.2019.02.009
KEYWORDS: diabetes mellitus type 2; diet; kidney function; lifestyle
ª 2019 International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Commentary on Page 638T 2DM affected 415 million people worldwide in2015 and it is expected that its prevalence will rise
up to 642 million people by 2040.1,2 One major threat in
these patients is the risk of diabetic kidney disease
(DKD) occurring in 20% to 40% of the T2DMspondence: Gozewijn D. Laverman, Ziekenhuis Groep Twente,
tment of Internal Medicine/Nephrology, Zilvermeeuw 1,
o 7609, the Netherlands. E-mail: g.laverman@zgt.nl
ved 31 July 2018; revised 4 February 2019; accepted 11
ary 2019; published online 21 February 2019population,3,4 which is 2 times higher than the preva-
lence rate of chronic kidney disease in the general
population.5 Diabetes complications can potentially be
prevented or delayed by modifying lifestyle (e.g.,
pursuing a healthy body weight, regular physical ac-
tivity, and a healthy diet).6 Decreasing the carbohy-
drate intake has strong effects in lowering blood
glucose and may contribute to counteract obesity,7 and
therefore a low-carbohydrate diet is recommended in
diabetes guidelines.6,8 However, decreasing the dietary
intake of carbohydrates naturally implies a higher
proportion of other dietary macronutrients.9 This is of
interest, because a high dietary intake of protein hasKidney International Reports (2019) 4, 710–719
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gressive impairment of renal function in chronic kid-
ney disease.10 Therefore, within the overall strategy to
delay the progression of renal function loss, the dietary
counseling in patients with DKD includes the advice to
limit the total protein intake to 0.8 g/kg per day.11
That the source of protein may also matter has
recently been demonstrated in a subgroup of patients
with T2DM included in the “Ongoing Telmisartan
Alone and in Combination with Ramipril Global
Endpoint Trial” (ONTARGET) study, suggesting that
animal protein, in particular, may increase the risk of
progressive DKD.12
We investigate the association between sources of
protein and prevalence of renal function impairment in
patients with T2DM. Furthermore, we performed a
theoretical replacement analysis, in which we assessed
the association of replacing macronutrients with both
animal and vegetable sources of protein on the preva-
lence of renal function impairment. This analysis can
provide valuable data on how to optimize the nutri-
tional guidelines of T2DM.
MATERIALS AND METHODS
Study Design
Cross-sectional analyses were performed in baseline data
of the DIAbetes and LifEstyle Cohort Twente-1 (DIA-
LECT-1) study. DIALECT-1 is an observational pro-
spective cohort study performed in the Ziekenhuis
Groep Twente Hospital (Almelo and Hengelo, The
Netherlands) that investigates the effect of lifestyle and
dietary habits on outcomes in patients with T2DM. Pa-
tients in DIALECT-1 were included between September
2009 and January 2016. The study was performed ac-
cording to the guidelines of good clinical practice and
the Declaration of Helsinki. Written informed consent
was obtained from all subjects before participation. It
has been approved by the local institutional review
boards (METC-registration numbers NL57219.044.16
and 1009.68020) and is registered in the Netherlands
Trial Register (NTR trial code 5855).
Patients
The study population consists of patients with T2DM
aged $18 years, treated in the outpatient clinic of the
Ziekenhuis Groep Twente Hospital as part of routine
secondary care. Patients depending on renal replace-
ment therapy or patients with insufﬁcient knowledge
of the Dutch language were excluded from
participation.
From 1082 patients as screened by electronic patient
ﬁles, 470 eligible patients were subsequently invited
for a baseline visit. After the baseline visit, 20 patients
were excluded because their correct diagnosis appearedKidney International Reports (2019) 4, 710–719to be type 1 diabetes mellitus, resulting in 450 patients
eligible in DIALECT-1.13 For the current study, we
excluded patients with missing data on dietary intake
(n ¼ 14) and physical activity (n ¼ 13) and patients
whose energy intake exceeded the borders of  3 SD of
the mean energy intake (n ¼ 3), leaving 420 patients for
analysis.
Dietary Assessment
Protein intake was assessed by using a semiquantitative
Food Frequency Questionnaire (FFQ). The FFQ was
developed and validated at the Wageningen University
in 2005. The FFQ asked the patient about dietary intake
of 177 items during the past month, taking seasonal
variation into account. For the present study, the FFQ
was slightly modiﬁed in 2009 for accurate assessment of
protein intake, including types and sources of protein.
For each item, the frequency was recorded in times per
day, week, or month. The number of servings was
expressed in natural units (e.g., slice of bread or apple)
or household measures (e.g., cup or spoon). The ques-
tionnaire was self-administered and ﬁlled out at home.
The ﬁlled-in questionnaires were checked for
completeness by a trained researcher, and inconsistent
answers were veriﬁed with the patients. Dietary data
were converted into daily nutrient intake using the
Dutch Food Composition Table of 2013.14 With respect
to the deﬁnition of animal and vegetable protein, the
Dutch Food Composition Table distinguishes between
these sources.
Additional analysis was performed within sub-
groups of animal and vegetable protein intake. All in-
dividual products were classiﬁed to animal or vegetable
protein according to the highest content and grouped
according to the Guidelines of Healthy Nutrition. We
used the total protein content of the products because
multiple products contain both animal and vegetable
protein. The subgroups and the corresponding food
items are shown in Appendix S1.
Outcome Measurement
Renal function is assessed by the eGFR, based on the
Chronic Kidney Disease Epidemiology Collaboration
formula,15 which is based on serum creatinine levels
(mmol/l), gender, and age. We deﬁned renal function
impairment as an eGFR <60 ml/min per 1.73 m2,16 and
performed additional tests with eGFR as the continuous
variable. Renal function was assessed at the same time
point that dietary information was collected.
Covariates
During the study visit, we collected information rele-
vant to the medical condition and pharmacological
treatment. Body weight (kg), height (cm), and waist711
TRANSLATIONAL RESEARCH MM Oosterwijk et al.: Vegetable Protein and Renal Function Impairmentand hip circumference (cm) were measured and the
body mass index (BMI) was calculated as weight
divided by the squared height (kg/m2). Information
about lifestyle exposures (e.g., smoking and physical
activity) was collected by a self-administered ques-
tionnaire. Physical activity was assessed by the previ-
ously validated Short Questionnaire to Assess Health
enhancing physical activity questionnaire.17 An activ-
ity score is calculated based on minutes of activity per
day multiplied by an intensity factor. We scored which
patients meet the Dutch Healthy Exercise Norm of 30
minutes moderate intense activity a day for at least 5
days a week.18 Blood pressure was measured in a su-
pine position by an automated device (Dinamap; GE
Medical Systems, Milwaukee, WI) for 15 minutes with
a 1-minute interval. The mean systolic and diastolic
blood pressure of the last 3 measurements was used for
analysis.
Patients were asked to collect their 24-hour urine to
obtain the urinary excretion of sodium as objective
measure of sodium intake, by multiplying these con-
centrations with the volume of the 24-hour urine
collection. Patients were instructed to store the canister
in a dark cool place, preferably in a refrigerator.
Routine laboratory tests were performed in nonfasting
venous blood, including renal function tests and
HbA1c.
Statistical Analysis
All statistical analyses were performed using IBM SPSS
for Windows (version 23.0; IBM Corp., Armonk, NY).
Normally distributed data are presented as mean  SD,
skewed variables are presented as median [interquartile
range] and dichotomous variables are presented in
number (percentage). A 2-tailed P value less than 0.05
was considered statistically signiﬁcant.
Total, animal, and vegetable protein intake, as well
as other macronutrients in the model, were adjusted for
total energy intake by the residual method.19 There-
fore, we used the mean total caloric intake of our T2DM
population in the regression equations. Patients were
divided according to gender-speciﬁc tertiles of energy-
adjusted total protein intake. Normality of data was
assessed by visually inspecting the frequency histo-
grams of each variable. Differences in characteristics
between these tertiles were tested using the 1-way
analysis of variance for normally distributed variables,
the Kruskal-Wallis test for skewed variables, and the
c2 test for dichotomous variables.
Univariate and multivariate Cox proportional hazard
models with time to event set to 1 year were used to
calculate prevalence ratios for renal function impair-
ment in each gender-speciﬁc tertile of total, animal, and
vegetable protein intake.20,21 Because of linear712associations when using tertiles and to retain power,
continuous variables of total, animal, and vegetable
protein intake and the eGFR were used in a linear
regression model to calculate regression coefﬁcients for
each incremental SD of total, animal, and vegetable
protein intake on the eGFR.
Confounders were based on relevant differences in
characteristics across total protein intake in the base-
line table and previous literature.22,23 Model 1 showed
the crude study outcomes, and model 2 was adjusted
for age. In the linear regression model, model 2 was
additionally adjusted for gender. Model 3 was addi-
tionally adjusted for lifestyle variables; that is, diabetes
duration (years), BMI (kg/m2), smoking status (current,
former, never), physical activity (meet the Dutch
Healthy Exercise Norm of 30 minutes moderate intense
activity a day for at least 5 days a week), and alcohol
intake (<1 unit per month, 1 unit per month – 1 unit
per day, >1 unit per day). Model 4 was additionally
adjusted for the energy-adjusted dietary factors like
saturated fat intake (g/d), unsaturated fat intake (g/d),
intake of mono- and disaccharides (g/d), intake of
polysaccharides (g/d), intake of trans fatty acids (g/d),
and intake of ﬁber (g/d). In model 4, vegetable protein
was adjusted for animal protein intake, and vice versa.
Urinary phosphorus excretion (mmol/24 hours) was
additionally tested as confounder, to investigate po-
tential differences in bioavailability of phosphorus in
tertiles of vegetable and animal protein intake.24
To identify effect modiﬁers, multiple interaction
terms were included in the model. In case of a signif-
icant interaction term, we performed a stratiﬁed anal-
ysis using the fully adjusted model. The use of renin
angiotensin aldosterone system (RAAS) inhibitors was
additionally tested as an interaction term, because it
has been described that the use of RAAS inhibitors
interacted with a low-protein diet to cause a short-term
decrease in eGFR.25
To investigate the hypothetical prevalence of renal
function impairment when replacing other macronu-
trients with dietary protein, several theoretical
replacement models were used.23,26 A new total energy
intake was calculated based on the contribution of 7
macronutrients, represented in energy percent: vege-
table protein, animal protein, saturated fatty acids,
unsaturated fatty acids, mono- and disaccharides,
polysaccharides, and alcohol. These energy-adjusted
variables were expressed as continuous variables per
3% of energy intake in the fully adjusted model, as this
best matched with the level and variation of intake of
the macronutrients. To investigate the inﬂuence of
replacing animal protein, vegetable protein was
included in the model, together with total energy
intake and mono- and disaccharides, polysaccharides,Kidney International Reports (2019) 4, 710–719
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animal protein). Each nutritional variable in the model
represents the difference in risk on renal function
impairment when increasing its intake with 3% of
energy, while keeping the other variables constant, at
the expense of 3% of energy from animal protein,
which was not included in the model.
Sensitivity analysis was performed in which we
repeated analyses after exclusion of alcohol intake from
the calculation of total energy intake.
RESULTS
Baseline Characteristics
Baseline characteristics by gender-speciﬁc tertiles of
energy-adjusted total protein intake are shown in
Table 1. The total population (n ¼ 420) included 57%
male participants, mean age was 63  9 years, and
mean BMI was 32.9  6.3 kg/m2, reﬂecting a pre-
dominantly obese T2DM population. Mean total pro-
tein intake was 78  12 g/d, corresponding with an
intake of 0.83 g/kg per day. Mean animal protein intake
was 51  13 g/d and mean vegetable protein intake was
28  5 g/d. Vegetable protein intake across tertiles of
total protein intake did not change (P ¼ 0.23), whereas
animal protein is signiﬁcantly positively associated
with total protein intake (P < 0.01), illustrating that
the variance in total protein intake is determined by
the variance in animal protein intake. Intake of un-
saturated fat and carbohydrates were signiﬁcantly
lower in the highest tertile of protein intake compared
with the lowest tertile of intake. In the highest tertile of
total protein intake, patients tended to have a higher
BMI, a higher total energy intake, a lower prevalence of
retinopathy, and there were fewer current smokers
compared with the lowest tertile of total protein intake.
In the lowest tertile of total protein intake, patients had
a signiﬁcantly lower prevalence of albuminuria.
Protein Intake and Prevalence of Renal Function
Impairment
Among 420 patients with T2DM in this cohort, 99 renal
function impairment cases were identiﬁed, corre-
sponding with a prevalence rate of 23.6%. The lowest
number of cases was found in the highest tertile of
energy-adjusted vegetable protein intake. In the
multivariate model in which we adjusted for lifestyle
and dietary factors, higher vegetable protein intake
was signiﬁcantly associated with a lower prevalence of
renal function impairment. The prevalence ratio in the
fully adjusted model was 1 (reference category), 0.74
(95% CI: 0.44–1.27; P ¼ 0.28) and 0.47 (95% CI: 0.23–
0.98; P ¼ 0.04) according to increasing tertiles of
vegetable protein intake (Table 2). In the highest tertile
of vegetable protein intake there was a 56% lowerKidney International Reports (2019) 4, 710–719prevalence of renal function impairment. No associa-
tion with renal function impairment was found across
tertiles of animal protein intake. In the second tertile,
the prevalence ratio was 1.10 (95% CI: 0.64–1.88; P ¼
0.74) and in the third tertile 1.06 (95% CI: 0.56–1.99;
P ¼ 0.87) compared with the bottom tertile.
Protein Intake and eGFR as Continuous Variable
Linear regression analysis with total, animal, and
vegetable protein intake and eGFR as continuous var-
iables showed almost similar results. The incremental
intake of 1 SD of vegetable protein intake in the fully
adjusted model was associated with a higher eGFR of
6.45 ml/min per 1.73 m2 (95% CI: 3.05–9.85; P < 0.01)
(Table 3). The incremental intake of 1 SD of total and
animal protein in the fully adjusted model was not
signiﬁcantly associated with alterations in the eGFR.
For each incremental SD of total protein, the eGFR was
estimated to be 0.23 (95% CI: 2.83 to 2.38; P¼ 0.86)
lower, as well as the incremental SD of animal protein
intake for which the eGFR was estimated to be 0.53
(95% CI: 3.36 to 2.30; P ¼ 0.71) lower.
Replacement of Macronutrients by Protein
Sources
Theoretical replacement models for vegetable protein
instead of saturated fat, unsaturated fat, mono- and
disaccharides and polysaccharides showed signiﬁcantly
lower prevalence ratios of renal function impairment
(Table 4, model 9–12). Replacing intake of 3 energy
percent from animal protein by vegetable protein
instead (model 13) lowered the prevalence ratio for the
association with renal function impairment to 0.20
(95% CI: 0.06–0.63; P ¼ 0.01). Replacement of total and
animal protein instead of these macronutrients did not
statistically signiﬁcantly inﬂuence the prevalence ratio
of renal function impairment (model 1–7). Replacing
intake of 3 energy percent from vegetable protein by
animal protein instead (model 9) increased the preva-
lence ratio of renal function impairment to 1.31 (95%
CI: 0.94–1.83; P ¼ 0.13).
Additional Analyses
The interaction term of total protein intake and use of
RAAS inhibitors in the linear regression analysis was
not signiﬁcantly associated with a higher eGFR of 2.67
per incremental SD of total protein intake (95%
CI: 0.78 to 6.11; P ¼ 0.13); however, the use of RAAS
inhibitors itself was signiﬁcantly associated with a
lower eGFR of 25.36 (95% CI: 48.51 to 2.22; P ¼
0.03). Other variables in the fully adjusted model show
no signiﬁcant interaction terms.
Urinary phosphorus excretion was signiﬁcantly
lower in those with a reduced eGFR (23.9  7.6 mmol/713
Table 1. Baseline characteristics by gender-speciﬁc tertiles of energy-adjusted total protein intake of 420 patients with type 2 diabetes mellitus
in the DIAbetes and LifEstyle Cohort Twente-1 population
Total population Tertile 1 Tertile 2 Tertile 3 P
n 420 140 140 140
Age (yr) 63  9 63  9 63  9 63  9 0.87
Diabetes duration [yr] 11 [6–18] 11 [7–19] 12 [7–18] 11 [4–17] 0.16
BMI (kg/m2) 32.9  6.3 32.8  5.9 32.2  6.2 33.7  6.6 0.11
Waist-hip ratioa 1.00  0.09 1.00  0.10 1.00  0.09 1.01  0.09 0.55
Smoking, n (%) 0.19
Current smoker 65 (16) 26 (19) 23 (16) 16 (11)
Former smoker 227 (54) 67 (48) 82 (59) 78 (56)
Never smoker 128 (31) 47 (34) 35 (25) 46 (33)
Alcohol intake, n (%) 0.85
Low (<1 unit/mo) 164 (39) 51 (36) 60 (43) 53 (38)
Moderate (1 unit/mo – 1 unit/d) 136 (32) 48 (34) 42 (30) 46 (33)
High (>1 unit/d) 120 (29) 41 (29) 38 (27) 41 (29)
Physical activity – adherence to the Dutch
Healthy Exercise Norm, n (%)
249 (59) 85 (61) 83 (59) 81 (58) 0.89
Systolic blood pressure (mm Hg) 136  16 137  17 137  16 135  16 0.67
Diastolic blood pressure (mm Hg) 74  10 75  10 74  10 74  9 0.97
HbA1c (mmol/mol)a 57.3  11.9 56.3  11.2 57.8  13.0 57.7  11.5 0.52
Urinary urea excretion (mmol/24 h) 414  148 363  132 420  142 457  154 <0.01
Nutritional intake
Energy (kcal) 1898  603 1880  633 1851  576 1962  599 0.28
Protein (g/d) 78  12 66  7 77  3 90  8 <0.01
Animal protein (g/d) 51  13 40  8 50  6 64  11 <0.01
Vegetable protein (g/d) 28  5 28  5 29  5 28  6 0.23
Carbohydrates (g/d) 206  32 215  32 208  26 197  34 <0.01
Mono/disaccharides (g/d) 93  26 99  30 93  22 88  25 0.01
Polysaccharides (g/d) 111  24 113  26 113  23 107  23 0.07
Fat (g/d) 77  12 78  11 77  11 76  13 0.51
SFA (g/d) 27  6 27  6 26  5 28  6 0.06
UFA (g/d) 43  8 44  8 43  8 41  8 0.01
Transfat (g/d) 1.71  0.43 1.74  0.42 1.66  0.39 1.73  0.47 0.29
Fiber (g/d) 21  5 20  4 21  4 21  5 0.22
Estimated sodium intake (mg/d)a,b 4250  1833 4006  1744 4334  1687 4404  2033 0.16
Complications, n (%)
Microvascular complications 276 (66) 88 (63) 94 (67) 94 (67) 0.68
Retinopathya 102 (24) 39 (28) 37 (26) 26 (19) 0.15
Neuropathy 150 (36) 48 (34) 48 (34) 54 (39) 0.69
Diabetic kidney diseasea 169 (40) 52 (37) 62 (45) 55 (39) 0.43
Albuminuriaa 122 (29) 30 (22) 50 (36) 42 (30) 0.03
eGFR <60 ml/min per 1.73 m2 99 (24) 36 (26) 33 (24) 30 (21) 0.70
Macrovascular complications 148 (35) 53 (38) 50 (36) 45 (32) 0.60
Medication use, n (%)
RAAS inhibitors 281 (67) 95 (68) 88 (63) 98 (70) 0.43
Insulin use 263 (63) 83 (59) 92 (66) 88 (63) 0.54
Diuretics 218 (52) 75 (54) 68 (49) 75 (54) 0.63
RAAS, renin angiotensin aldosterone system; SFA, saturated fatty acids; UFA, unsaturated fatty acids.
aMissing values for waist-hip ratio (n ¼ 6), HbA1c (n ¼ 1), urinary urea excretion (n ¼ 42), estimated sodium intake (n ¼ 5), retinopathy (n ¼ 2), diabetic kidney disease (n ¼ 1), and
albuminuria (n ¼ 2).
bBased on 24-hour urinary sodium excretion.
The cutoff points for male patients were set at 71.8 g/d and 80.9 g/d and for female patients at 75.1 g/d and 83.2 g/d.
TRANSLATIONAL RESEARCH MM Oosterwijk et al.: Vegetable Protein and Renal Function Impairment24 hours in patients with chronic kidney disease [CKD]
versus 28.4  12.4 mmol/24 hours in patients without
CKD, P < 0.01). In addition, patients with CKD
consume signiﬁcantly less vegetable protein (27.2  4.4
g/d in patients with CKD vs. 28.8  5.6 g/d in patients
without CKD, P < 0.01). However, there was no dif-
ference in urinary phosphorus excretion across tertiles
of vegetable protein intake (28.3  12.9 vs. 25.8  10.1
714vs. 28.0  11.2 mmol/24 hours for tertiles 1, 2, and 3,
respectively, P ¼ 0.14).
In food group analyses, we found that red meat and
dairy were the most important contributors to animal
protein intake (Appendix S2). Red meat is associated
with a higher prevalence of renal function impairment
in the third tertile compared with the bottom tertile
(prevalence ratio: 1.41; 95% CI: 0.83–2.41; P ¼ 0.21),Kidney International Reports (2019) 4, 710–719
Table 2. Prevalence ratios (95% conﬁdence interval) for renal
function impairment (estimated glomerular ﬁltration rate <60 ml/min
per 1.73 m2) by gender-specific tertiles of energy-adjusted total,
animal, and vegetable protein intake among 420 patients with type 2
diabetes mellitus from the DIAbetes and LifEstyle Cohort Twente-1
population
Tertile 1 Tertile 2 Tertile 3
Total protein
Mean  SD 66.1  6.6 77.5  2.9 90.2  8.2
Cases 36 33 30
Model 1 1 0.92 (0.57–1.47) 0.83 (0.51–1.35)
Model 2 1 0.87 (0.54–1.39) 0.79 (0.49–1.28)
Model 3 1 0.88 (0.54–1.41) 0.78 (0.48–1.28)
Model 4 1 0.91 (0.55–1.53) 0.84 (0.45–1.58)
Vegetable protein
Mean  SD 23.3  3.1 28.1  1.0 34.0  4.3
Cases 40 36 23
Model 1 1 0.90 (0.57–1.41) 0.58 (0.34–0.96)
Model 2 1 0.82 (0.52–1.29) 0.59 (0.35–0.99)
Model 3 1 0.81 (0.51–1.29) 0.58 (0.34–0.98)
Model 4 1 0.74 (0.44–1.27) 0.47 (0.23–0.98)
Animal protein
Mean  SD 38.6  7.5 50.6  3.2 65.1  9.4
Cases 30 33 36
Model 1 1 1.10 (0.67–1.80) 1.20 (0.74–1.95)
Model 2 1 1.09 (0.66–1.78) 1.12 (0.69–1.81)
Model 3 1 1.10 (0.67–1.80) 1.10 (0.67–1.80)
Model 4 1 1.10 (0.64–1.88) 1.06 (0.56–1.99)
Model 1: unadjusted model
Model 2: adjusted for age (years)
Model 3: model 2 and additionally adjusted for diabetes duration (years), body mass
index (kg/m2), smoking (current, former, never), physical activity (meet the Dutch
Healthy Exercise Norm) and alcohol intake (<1 unit per month, 1 unit per month – 1 unit
per day, >1 unit per day)
Model 4: model 3 and additionally adjusted for saturated fat intake (g/d), unsaturated fat
intake (g/d), intake of mono- and disaccharides (g/d), intake of polysaccharides (g/d),
intake of ﬁber (g/d), and intake of trans fatty acids (g/d)
Table 3. Regression coefﬁcients for the estimated glomerular
ﬁltration rate by energy-adjusted total, animal, and vegetable protein
intake among 420 patients with type 2 diabetes mellitus from the
DIAbetes and LifEstyle Cohort Twente-1 population
Regression coefﬁcient per SD
Total protein
Mean  SD 77.9  11.7
Model 1 0.06 (2.27 to 2.38)
Model 2 0.51 (1.44 to 2.47)
Model 3 0.76 (1.19 to 2.72)
Model 4 0.23 (2.83 to 2.38)
Vegetable protein
Mean  SD 28.4  5.4
Model 1 2.95 (0.65 to 5.26)
Model 2 2.59 (0.66 to 4.51)
Model 3 2.63 (0.66 to 4.60)
Model 4 6.45 (3.05 to 9.85)
Animal protein
Mean  SD 51.4  13.0
Model 1 1.19 (3.51 to 1.14)
Model 2 0.64 (2.59 to 1.32)
Model 3 0.39 (2.36 to 1.58)
Model 4 0.53 (3.36 to 2.30)
Model 1: unadjusted model
Model 2: adjusted for age (years)
Model 3: model 2 and additionally adjusted for diabetes duration (years), body mass
index (kg/m2), smoking (current, former, never), physical activity (meet the Dutch
Healthy Exercise Norm), and alcohol intake (<1 unit per month, 1 unit per month – 1 unit
per day, >1 unit per day)
Model 4: model 3 and additionally adjusted for saturated fat intake (g/d), unsaturated fat
intake (g/d), intake of mono- and disaccharides (g/d), intake of polysaccharides (g/d),
intake of ﬁber (g/d), and intake of trans fatty acids (g/d)
MM Oosterwijk et al.: Vegetable Protein and Renal Function Impairment TRANSLATIONAL RESEARCHwhereas dairy is not associated with renal function
impairment (prevalence ratio: 0.90; 95% CI: 0.52–1.58;
P ¼ 0.72) in the third tertile compared with the ﬁrst
tertile (Appendix S3). In the vegetable-based food
groups we see that cereals were the most important
contributors, associated with a nonsigniﬁcant lower
prevalence of renal function impairment (prevalence
ratio: 0.67; 95% CI: 0.35–1.28; P ¼ 0.22).
We performed sensitivity analyses in which we
repeated analyses after exclusion of alcohol intake from
the calculation of total energy intake. The results of
these analyses remained materially unchanged
compared with the primary analyses.
DISCUSSION
In this cross-sectional study among 420 patients with
long-standing T2DM, we investigated the relationship
between sources of dietary protein and renal function
impairment. The main ﬁnding was that vegetable pro-
tein intake was clearly associated with a lower preva-
lence of renal function impairment, and this association
was conﬁrmed when eGFR was analyzed as a continuousKidney International Reports (2019) 4, 710–719variable. Moreover, a replacement analysis shows an
inverse association with renal function impairment
when replacing animal protein with vegetable protein.
A beneﬁcial association between vegetable protein
intake andDKDhaspreviouslybeen suggested in a review
that compared different dietary patterns and their effect
on DKD progression.27 However, extensive differences
exist between the various plant-based diets (e.g., soy-
based vs. non–soy-based, vegetarian vs. vegan diets)
and the total protein content could be lower in speciﬁc
plant-based diets compared with conventional diets.
We are aware of one other report evaluating dietary
protein sources in relation to renal function: a substudy
in patients with T2DM of the landmark “Ongoing Tel-
misartan Alone and in Combination with Ramipril
Global Endpoint Trial (ONTARGET)”.12 The ONTAR-
GET investigators studied prospectively the impact of
dietary protein source on development of DKD. They
found an almost signiﬁcant inverse association between
tertiles of absolute vegetable protein intake and devel-
opment of DKD during 5.5 years of follow-up (odds
ratio: 0.86; 95% CI: 0.74–1.01), which is in line with our
ﬁndings. However, the overall protein intake in
ONTARGET was lower compared with our study: 0.53
[0.34–0.82] versus 0.79 [0.58–1.07] g/kg per day for total
protein and 0.09 [0.03–0.17] versus 0.28 [0.19–0.39] g/kg715
Table 4. Prevalence ratios (95% conﬁdence intervals) for the
association of protein intake and renal function impairment per 3
energy percent from energy-adjusted total, animal, and vegetable
protein intake instead of other nutrients
Prevalence ratio (95% conﬁdence
interval)
Total protein
Model 1: protein instead of mono and
disaccharides
0.95 (0.75–1.21)
Model 2: protein instead of polysaccharides 1.01 (0.78–1.30)
Model 3: protein instead of SFA 1.03 (0.75–1.42)
Model 4: protein instead of UFA 0.99 (0.76–1.28)
Animal protein
Model 4: animal protein instead of mono and
disaccharides
0.98 (0.77–1.24)
Model 5: animal protein instead of
polysaccharides
0.92 (0.70–1.20)
Model 6: animal protein instead of SFA 1.03 (0.74–1.43)
Model 7: animal protein instead of UFA 0.99 (0.76–1.27)




Model 9: vegetable protein instead of mono and
disaccharides
0.19 (0.06–0.59)
Model 10: vegetable protein instead of
polysaccharides
0.25 (0.08–0.79)
Model 11: vegetable protein instead of SFA 0.20 (0.06–0.66)
Model 12: vegetable protein instead of UFA 0.20 (0.06–0.64)
Model 13: vegetable protein instead of animal
protein
0.20 (0.07–0.63)
SFA, saturated fatty acids; UFA, unsaturated fatty acids.
All models were adjusted for age (years), gender, diabetes duration (years), body mass
index (kg/m2), smoking (current, former, never), physical activity (meet the Dutch
Healthy Exercise Norm), alcohol intake (<1 unit per month, 1 unit per month – 1 unit per
day, >1 unit per day), saturated fat intake (g/d), unsaturated fat intake (g/d), intake of
mono- and disaccharides (g/d), intake of polysaccharides (g/d), intake of fiber (g/d), and
intake of trans fatty acids (g/d).
TRANSLATIONAL RESEARCH MM Oosterwijk et al.: Vegetable Protein and Renal Function Impairmentper day for vegetable protein. Because protein restric-
tion of 0.8 g/kg per day is reached more often in their
study, the results of ONTARGET could result from the
low total protein intake.
In addition to independent replication of the
ONTARGET study, the association between vegetable
protein intake and lower prevalence of renal function
impairment is strengthened by our theoretical
replacement model. This is an isocaloric model, in
which a new energy intake variable is calculated, based
on all macronutrients and is held constant.28,29 Partic-
ularly the clearly lower prevalence of renal function
impairment when replacing animal protein with vege-
table protein is of interest, because this beneﬁcial
replacement was also shown in a systematic review
with glycemic control as study outocome.30 Shifting
the focus of a lower carbohydrate content showed also
a strong signiﬁcant result related to the prevalence of
renal function impairment when replacing carbohy-
drates with vegetable protein. This beneﬁcial associa-
tion was also found in a prospective study with respect
to all-cause mortality in patients with T2DM.31716In comparison with other European diabetes pop-
ulations, the vegetable protein intake in our cohort was
more or less similar (27.5 g/d vs. 26.1 g/d), whereas the
total and animal protein intake were somewhat lower in
our study population (78.2 g/d vs. 94.2 g/d and 50.7 g/
d vs. 59.6 g/d, respectively),31 which probably reﬂects
regional differences in dietary habits.
Although the mechanisms behind the association
between vegetable protein and lower prevalence of renal
function impairment are unknown, it might be related to
harmful effects related to variable bioavailability of
phosphorus depending on the sources of protein. Phos-
phate in vegetable protein is complexed in the form of
phytic acid, which is less digestible compared with
phosphate from animal protein,32 and the more digest-
ible phosphate additives are commonly used in pro-
cessed foods of mainly animal origin.32,33 In contrast to
previous studies regarding source of protein and phos-
phaturia,24,33 however, we found no signiﬁcant differ-
ence in urinary phosphate excretion across tertiles of
vegetable protein intake (P¼ 0.14), whichmay be due to
variability in urinary phosphate excretion.
The strength of the DIALECT-1 cohort is that it re-
ﬂects the real world of patients with T2DM and it was
speciﬁcally designed to evaluate lifestyle characteristics
such as dietary habits, with minimal selection bias,
compared with clinical trial populations. Obviously,
the cross-sectional nature of the study prevents making
causal inferences about the dietary protein pattern and
renal function. We cannot completely rule out reverse
causation bias (i.e., that some patients had changed
their diet or other lifestyle habits after developing renal
function impairment), although this seems less likely
because none of the patients were followed in our
speciﬁc predialysis clinic. Further, we cannot distin-
guish between reversible hemodynamic effects of pro-
tein intake and chronic effects on development of
kidney damage. The protein intake was based on self-
report. Although the FFQ has some limitations, this is
still the best method available in studies of this size,
and the FFQ is a valid method to rank individuals ac-
cording to their intake and this was conﬁrmed by
objective measurements of urinary urea excretion.
With regard to dietary protein, the current Kidney
Disease: Improving Global Outcomes guideline recom-
mends a restricted total protein intake of 0.8 g/kg per
day in patients with T2DM and eGFR <30 ml/min per
1.73 m2.34 Previous research shows that each incre-
mental 0.1 g/kg per day of total protein intake increases
the risk for end-stage renal disease (hazard ratio: 1.05;
95% CI: 1.04–1.14) in patients with diabetes.35 This was
not conﬁrmed in our study, with a nonstatistically lower
eGFR of 0.23 ml/min per 1.73 m2 (95% CI: 2.83 to
2.38; P ¼ 0.86) for each incremental intake of 1 SDKidney International Reports (2019) 4, 710–719
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ONTARGET12 and ours, it seems that these recommen-
dations need to be reconsidered. The data strongly
suggest that it is important to differentiate between
intake of animal and vegetable protein. There is no ev-
idence for a beneﬁt of restricting vegetable protein and,
rather than focusing on protein restriction, it appears
more appropriate to replace animal proteins with vege-
table proteins. For T2DM in general, to maintain a
low-carbohydrate diet as recommended in diabetes
guidelines, a speciﬁc advice could be to focus on
replacement of carbohydrates with vegetable protein.
Without this speciﬁc notion, many patients will replace
carbohydrates for a large part by animal protein, which
seems unwarranted with the available evidence.
In the older literature, it has been described that the
use of RAAS inhibitors interacted with a low-protein
diet to cause a short-term decrease in eGFR.25 We did
not ﬁnd such an interaction, but it should be stated
that our study design was not appropriate to this end.
However, in patients treated with RAAS inhibitors it
may be wise to consider the development of hyper-
kalemia when increasing vegetable protein intake.36,37
Regarding protein-containing products, our results
indicate that red meat intake, in particular, is associ-
ated with a higher prevalence of renal function
impairment, although not signiﬁcant. Whereas this
item was not investigated in their study, the ONTAR-
GET investigators found with respect to vegetable
protein intake that frequent consumption of fruits
reduced the risk of DKD (ORDKD3vs1: 0.77; 95% CI:
0.64–0.92), which is in line with our ﬁndings.
These dietary approaches can be merged together as
being a plant-based diet in terms of decreasing red meat
intake and increasing the intake of cereals, fruits, and
nuts,38–42 which have previously been demonstrated to
contribute to an improved glycemic control in patients
with T2DM.43 In addition, other impacts of plant-based
diets have been clearly demonstrated: less acid load
which in turn slows CKD progression,44 a decrease in
inﬂammatory biomarkers45 and its contribution in
maintaining a metabolically balanced gut microbiota.46
From a patient perspective, it is difﬁcult to convert
from a predominantly animal protein diet to a vegan
diet. Therefore, food-based guidelines or nutritional
patterns would be of great value instead of nutrient-
based guidelines, especially for patients with T2DM
in whom conﬂicting advice is provided to address each
macrovascular complication. A prospective analysis to
investigate the longitudinal effects of both pharmaco-
logical and nutritional therapy on eGFR decline over
years is needed to improve our understanding of the
association between sources of protein intake and
progression of renal function impairment. However, aKidney International Reports (2019) 4, 710–719critical appraisal in evaluating the nutritional man-
agement of protein intake is adherence to the diet, so
establishing an infrastructure that allows the moni-
toring of adherence would be of great value.
CONCLUSION
In conclusion, we found that higher intake of vegetable
protein was associated with a lower prevalence of renal
function impairment, and theoretical replacement of
animal protein with vegetable protein was inversely
associated with renal function impairment among pa-
tients with T2DM.
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